Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "sales"
Home
Global Appetite for K-Food Drives Record Export Surge as Instant Noodles and Frozen Gimbap Soar
The global spread of Korean pop culture continues to drive unprecedented overseas demand for K-food products, with items like instant ramen, frozen...
06/02/2026, 02:27 ET
Why Your Summer Tumbler Goes "Pop": Essential Safety and Hygiene Tips for Hot Weather
As summer temperatures climb, personal tumblers become ubiquitous. Many fill them with iced coffee for the morning commute, while others mix protein...
06/02/2026, 02:27 ET
Eli Lilly to Acquire GC Biopharma’s Curevo Vaccine in Blockbuster $1.5 Billion Deal
GC Biopharma’s U.S. affiliate, Curevo Vaccine, is set to be acquired by global pharmaceutical giant Eli Lilly in a deal...
05/30/2026, 05:29 ET
Oscotec Ramps Up R&D: What Lies Beyond the Success of Lazertinib?
“It doesn’t end with lazertinib. Keep an eye out for the next candidate in line.” Oscotec is aggressively channeling...
05/21/2026, 22:00 ET
77 km Linking Sea and River: Busan’s ‘Seven Bridges Tour’ Returns
At 6:30 a. m. , the rhythmic hum of bicycle wheels echoes across Busan’s Gwangandaegyo Bridge.
05/15/2026, 04:44 ET
Celltrion to Acquire French Healthcare Specialist Gifrer, Eyeing European Pharmacy Market
Celltrion announced on the 12th its acquisition of Gifrer, a French healthcare specialist with a 114-year history.
05/14/2026, 01:07 ET
A Milestone for K-Bio: Celltrion’s Truxima Surpasses Global Blockbuster Rituxan in U.S. Prescriptions
Truxima , a blood cancer treatment developed by Celltrion, has become the first Korean-made biosimilar to rank number...
04/09/2026, 01:13 ET
YuhanUSA and Huinno Partner to Launch AI-Powered ECG Monitoring in the U.S.
YuhanUSA, the U.S. subsidiary of Yuhan Corporation, announced on the 30th that it has signed a strategic business...
04/03/2026, 02:32 ET
Sam Chun Dang Pharm Secures Exclusive U.S. Licensing Deal for Oral Obesity and Diabetes Treatment
Sam Chun Dang Pharm has entered into a significant license-out agreement with an undisclosed U. S.
04/01/2026, 04:58 ET
Celltrion Secures Japanese Approval for Xolair and Eylea Biosimilars
Celltrion announced on the 27th that it has obtained marketing authorization from Japan’s Ministry of Health, Labour...
03/30/2026, 02:30 ET
Previous
5
6
7
8
9
Next